...
首页> 外文期刊>Journal of pharmaceutical sciences. >Definition of a solvent system for spherical crystallization of salbutamol sulfate by quasi-emulsion solvent diffusion (QESD) method.
【24h】

Definition of a solvent system for spherical crystallization of salbutamol sulfate by quasi-emulsion solvent diffusion (QESD) method.

机译:通过准乳液溶剂扩散(QESD)方法定义硫酸沙丁胺醇球形结晶的溶剂系统的定义。

获取原文
获取原文并翻译 | 示例
           

摘要

In this paper we describe how the spherical crystallization process by QESD method can be applied to a water-soluble drug, salbutamol sulfate. The type of solvent, antisolvent, and emulsifier and the concentration of emulsifier to be used for the production of spherical particles with a size range 80-500 microm are determined. Furthermore, the solvent/antisolvent ratio and the temperature difference between them (Delta T) are studied. It was observed that, in the case of salbutamol sulfate, the Delta T value has no influence on the formation of spherical particles. A very large metastable zone of salbutamol sulfate in water could explain this phenomenon. Finally, the influence of emulsifier concentration and of maturation time on the size of spherical particles is studied. The results show that these two parameters must be fixed to control the size of the recovered particles.
机译:在本文中,我们描述了如何将QESD方法的球形结晶过程应用于水溶性药物硫酸沙丁胺醇。确定用于生产尺寸范围为80-500微米的球形颗粒的溶剂,抗溶剂和乳化剂的类型以及乳化剂的浓度。此外,研究了溶剂/反溶剂比和它们之间的温差(ΔT)。观察到,在硫酸沙丁胺醇的情况下,ΔT值对球形颗粒的形成没有影响。水中的沙丁胺醇硫酸盐非常大的亚稳区可以解释这种现象。最后,研究了乳化剂浓度和成熟时间对球形颗粒尺寸的影响。结果表明,必须固定这两个参数以控制回收颗粒的大小。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号